Hossein Mazandarani

5-Fluoro-2-methyl-<i>N</i>-[4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>]- [1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985):  An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors

J. Donald Albright, Marvin F. Reich, Efren G. Delos Santos et al. · Journal of Medicinal Chemistry · 1998 · 149 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Discovery of 5-Arylsulfonamido-3- (pyrrolidin-2-ylmethyl)-1<i>H</i>-indole Derivatives as Potent, Selective 5-HT₆Receptor Agonists and Antagonists

Derek C. Cole, William J. Lennox, Sabrina Lombardi et al. · Journal of Medicinal Chemistry · 2004 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

WAY-163909 [(7 bR, 10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

John Dunlop, Annmarie L. Sabb, Hossein Mazandarani et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 100 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503

Sharon Rosenzweig‐Lipson, Jean Zhang, Hossein Mazandarani et al. · Brain Research · 2006 · 78 citations

Medicine, Endocrinology, Pharmacology +13

Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist

John Dunlop, Stephanie W. Watts, James E. Barrett et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 49 citations

Medicine, Medicinal Chemistry, Pharmacology +16